Why the study?
Long-term outcomes of takotsubo syndrome and the factors associated with death or recurrence needed evaluation.
Does treatment with beta-blockers reduce the risk of death or recurrence in patients with takotsubo syndrome?
Population
519 consecutive patients with confirmed takotsubo syndrome
Design
Retrospective population-based cohort study
Follow-up
5.2 years (IQR 3.0–7.2)
Authors
Loading...
May support beta-blocker use in takotsubo syndrome; leaves open confirmation in randomized trials.
Does treatment with beta-blockers reduce the risk of death or recurrence in patients with takotsubo syndrome?
Treatment with beta-blockers is associated with improved event-free survival (lower risk of recurrence or death) in patients with takotsubo syndrome.
Lau et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: